Cytiva Xcellerex Automated Perfusion System (APS)

Monday, 21 September, 2020 | Supplied by: Global Life Sciences Solutions


Cytiva’s Xcellerex Automated Perfusion System (APS) is designed to support the biotech industry’s move to continuous manufacturing, simplifying processes and reducing risk when intensifying upstream operations.

In cell cultivation using perfusion, media is continuously fed and product harvested. This increases output compared to traditional batch or fed batch methods, yet perfusion processes still involve substantial manual work and risk. Overcoming this challenge by simplifying and automating upstream operations would alleviate bottlenecks further along the perfusion process, increasing overall productivity and output.

Xcellerex APS integrates with Cytiva’s Xcellerex XDR bioreactors for continuous upstream bioprocessing operations. The system’s automation capabilities include automated filter switching, liquid management and cell bleed, reducing risk for human error and increasing process robustness.

Online: www.cytivalifesciences.com/en/au
Phone: 1800 150 522
Related Products

Terumo K-Pack Embrace active safety needle

The K-Pack Embrace active safety needle is packaged in a rigid cap and case container, designed...

Scientifica PatchPad Evo electrophysiology controller

Scientifica introduces PatchPad Evo, a next-generation electrophysiology controller that provides...

AdipoGen Cystatin C (mouse) (monomer):Fc (silent) InVivoKine fusion proteins

InVivoKines are a new generation of recombinant fusion proteins for immunotherapeutic,...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd